Home / Diabetes In Control (page 264)

Diabetes In Control

Gut Hormones and Bariatric Surgery

Human subjects with severe obesity are increasingly treated with bariatric surgery to promote weight loss via procedures that reduce the capacity of the stomach and/or the absorptive surface area of the small bowel, resulting in reduced food intake and/or energy malabsorption. Some of these surgical procedures may also be associated …

Read More »

Letter from the Editor, #738: Afrezza

After a long battle and comments from many doubters the FDA has approved the inhaled insulin, Afrezza. As soon as the approval came the nay-sayers were quick to remind us of what a failure Exubera had been and there was no way that this new inhaled insulin stood a chance. …

Read More »

Genteel – The First Pain Free Lancing Instrument

Genteel-image

Genteel – The First Pain Free Lancing Instrument  Genteel is a radically new lancing instrument that completely replaces the more-familiar industry-standard spring-loaded devices. Genteel’s patented technology allows patients to get the right amount of test blood from both fingers and alternate sites the first time, every time, without pain, or …

Read More »

Hydrogen Sulfide Has Potential Diabetes and CVD Health Benefits

It may have a reputation for being highly toxic, but when used in the right tiny dosage, hydrogen sulfide may offer potential health benefits for a range of issues, from diabetes to stroke, heart attacks and dementia. A new compound (AP39), could hold the key to future therapies, by targeting …

Read More »

Group Education Better than Individual Counseling

A new study examining individual counseling for self-care in patients with diabetes vs group education has found that the latter is associated with better outcomes. The research was carried out with more than 75,000 patients. Compared with those attending individual counseling, patients who went to group classes were less likely …

Read More »

Diabetes Drug Cuts Alzheimer’s Risk

Previous studies have suggested that people given pioglitazone for type 2 diabetes were less likely to develop Alzheimer’s or other forms of dementia. German researchers tracked a database of about 146,000 patients age 60 and older who initially did not have evidence of dementia. They speculated that pioglitazone helped prevent …

Read More »